140 related articles for article (PubMed ID: 24348388)
1. Successful chemotherapy with Carboplatin and s-1 for thymic carcinoma: a case report.
Igawa S; Yanagisawa N; Ishihara M; Kimura M; Maki S; Otani S; Sasaki J; Masuda N
Case Rep Oncol; 2013; 6(3):526-30. PubMed ID: 24348388
[TBL] [Abstract][Full Text] [Related]
2. nab-Paclitaxel in Combination with Carboplatin for a Previously Treated Thymic Carcinoma.
Makimoto G; Fujiwara K; Watanabe H; Kameyama N; Matsushita M; Rai K; Sato K; Yonei T; Sato T; Shibayama T
Case Rep Oncol; 2014 Jan; 7(1):14-7. PubMed ID: 24575009
[TBL] [Abstract][Full Text] [Related]
3. Successful Treatment of Advanced Thymic Carcinoma with Carboplatin plus
Araya T; Kita T; Matsuoka H; Sakai T; Kimura H; Kasahara K
Case Rep Oncol; 2020; 13(3):1506-1512. PubMed ID: 33564291
[TBL] [Abstract][Full Text] [Related]
4. Response to chemotherapy with carboplatin plus albumin-bound paclitaxel in a patient with lymphoepithelioma-like thymic carcinoma: A case report.
Shima H; Ozasa H; Tsuji T; Ajimizu H; Nomizo T; Yagi Y; Sakamori Y; Nagai H; Minamiguchi S; Kim YH; Mishima M
Mol Clin Oncol; 2016 May; 4(5):715-718. PubMed ID: 27123268
[TBL] [Abstract][Full Text] [Related]
5. Second-line chemotherapy of platinum compound plus CPT-11 following ADOC chemotherapy in advanced thymic carcinoma: analysis of seven cases.
Kanda S; Koizumi T; Komatsu Y; Yoshikawa S; Okada M; Hatayama O; Yasuo M; Tsushima K; Urushihata K; Kubo K; Sasabayashi M; Takamizawa A
Anticancer Res; 2007; 27(4C):3005-8. PubMed ID: 17695487
[TBL] [Abstract][Full Text] [Related]
6. Successful chemotherapy with carboplatin and nab-paclitaxel for thymic large cell neuroendocrine carcinoma: A case report.
Igawa S; Yanagisawa N; Niwa H; Ishihara M; Hiyoshi Y; Otani S; Katono K; Sasaki J; Satoh Y; Masuda N
Oncol Lett; 2015 Dec; 10(6):3519-3522. PubMed ID: 26788161
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy with paclitaxel plus carboplatin for relapsed advanced thymic carcinoma.
Song Z
J Thorac Dis; 2014 Dec; 6(12):1808-12. PubMed ID: 25589977
[TBL] [Abstract][Full Text] [Related]
8. First-Line Treatment with Carboplatin plus
Funaishi K; Yamasaki M; Saito N; Daido W; Ishiyama S; Deguchi N; Taniwaki M; Ohashi N
Case Rep Oncol; 2017; 10(2):571-576. PubMed ID: 28868014
[TBL] [Abstract][Full Text] [Related]
9. Combination chemotherapy with doxorubicin, vincristine, cyclophosphamide, and platinum compounds for advanced thymic carcinoma.
Agatsuma T; Koizumi T; Kanda S; Ito M; Urushihata K; Yamamoto H; Hanaoka M; Kubo K
J Thorac Oncol; 2011 Dec; 6(12):2130-4. PubMed ID: 21892103
[TBL] [Abstract][Full Text] [Related]
10. Combination carboplatin and nab-paclitaxel as a first-line treatment for advanced thymic carcinoma.
Manaka H; Igawa S; Yamamoto M; Oguri A; Manabe H; Kasajima M; Kusuhara S; Hosotani S; Nakahara Y; Sato T; Fukui T; Hisashi M; Sasaki J; Naoki K
Invest New Drugs; 2023 Feb; 41(1):115-121. PubMed ID: 36633784
[TBL] [Abstract][Full Text] [Related]
11. [Successful treatment of intrapericardial administration of carboplatin following systemic chemotherapy in a case of advanced thymic cancer with cardiac tamponade].
Okada M; Koizumi T; Yasuo M; Tsushima K; Urushihata K; Yamaguchi S; Hanaoka M; Fujimoto K; Kubo K
Nihon Kokyuki Gakkai Zasshi; 2006 Dec; 44(12):968-72. PubMed ID: 17233396
[TBL] [Abstract][Full Text] [Related]
12. Bevacizumab in combination with paclitaxel and platinum for previously treated advanced thymic epithelial tumors.
Wang CL; Gao LT; Lyu CX; Zhang Q; Zeng WQ; Fang WT; Zhu L; Fu XL
Med Oncol; 2022 Jan; 39(2):25. PubMed ID: 34982283
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of Amrubicin combined with carboplatin for thymic carcinoma and invasive thymoma: North Japan Lung Cancer group study 0803.
Inoue A; Sugawara S; Harada M; Kobayashi K; Kozuki T; Kuyama S; Maemondo M; Asahina H; Hisamoto A; Nakagawa T; Hotta K; Nukiwa T
J Thorac Oncol; 2014 Dec; 9(12):1805-9. PubMed ID: 25393793
[TBL] [Abstract][Full Text] [Related]
14. Key components of chemotherapy for thymic malignancies: a systematic review and pooled analysis for anthracycline-, carboplatin- or cisplatin-based chemotherapy.
Okuma Y; Saito M; Hosomi Y; Sakuyama T; Okamura T
J Cancer Res Clin Oncol; 2015 Feb; 141(2):323-31. PubMed ID: 25146529
[TBL] [Abstract][Full Text] [Related]
15. Amrubicin as second-line and beyond treatment for platinum-refractory advanced thymic carcinoma.
Hirai F; Seto T; Yamanaka T; Toyozawa R; Inamasu E; Kojo M; Toyokawa G; Morodomi Y; Shiraishi Y; Takenaka T; Yamaguchi M; Takenoyama M; Ichinose Y
Jpn J Clin Oncol; 2013 Oct; 43(10):1018-22. PubMed ID: 23917962
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of chemotherapy with carboplatin and paclitaxel for unresectable thymic carcinoma.
Igawa S; Murakami H; Takahashi T; Nakamura Y; Tsuya A; Naito T; Kaira K; Ono A; Shukuya T; Tamiya A; Endo M; Yamamoto N
Lung Cancer; 2010 Feb; 67(2):194-7. PubMed ID: 19409644
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy with carboplatin and paclitaxel after failure of primary chemotherapy for advanced thymic carcinoma. A report of three cases and review of the literature.
Watanabe K; Shinkai M; Goto H; Yoshikawa S; Yamaguchi N; Hara Y; Shinoda M; Moriyama Y; Rubin BK; Ishigatsubo Y; Kaneko T
Tumori; 2013; 99(4):e172-6. PubMed ID: 24326856
[TBL] [Abstract][Full Text] [Related]
18. Good Response of Advanced Thymic Carcinoma with Low PD-L1 Expression to Chemotherapy plus Pembrolizumab as First-Line Therapy and to Pembrolizumab as Maintenance Therapy: A Case Report.
Nishii Y; Furuhashi K; Ito K; Sakaguchi T; Suzuki Y; Fujiwara K; Yasuma T; Kobayashi T; D'Alessandro-Gabazza CN; Gabazza EC; Taguchi O; Hataji O
Pharmaceuticals (Basel); 2022 Jul; 15(7):. PubMed ID: 35890187
[TBL] [Abstract][Full Text] [Related]
19. Salvage chemotherapy with carboplatin and paclitaxel for cisplatin-resistant thymic carcinoma--three cases.
Komatsu Y; Koizumi T; Tanabe T; Hatayama O; Yasuo M; Okada M; Yamamoto H; Kubo K; Sasabayashi M; Tsunoda T
Anticancer Res; 2006; 26(6C):4851-5. PubMed ID: 17214351
[TBL] [Abstract][Full Text] [Related]
20. Lenvatinib-refractory thymic mucinous carcinoma with
Tsukaguchi A; Ihara S; Yasuoka H; Minami S
Int Cancer Conf J; 2023 Jan; 12(1):36-40. PubMed ID: 36605843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
